---
category: listing
circular_id: 490c04e3913314d2
date: '2025-11-28'
description: SUDEEP PHARMA LIMITED will be added to the BSE IPO Index effective December
  02, 2025, following its listing on BSE on November 28, 2025.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={7158D442-5248-42DA-9A8B-D17C565E56A7}&noticeno=20251128-12&dt=11/28/2025&icount=12&totcount=56&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine index addition following IPO listing; impacts only index composition
  tracking with no regulatory or compliance implications for market participants
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251128-12&attachedId=
processing:
  attempts: 1
  content_hash: 3289eff1b5922edb
  processed_at: '2025-11-28T15:43:28.336865'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-11-28T10:41:06+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={7158D442-5248-42DA-9A8B-D17C565E56A7}&noticeno=20251128-12&dt=11/28/2025&icount=12&totcount=56&flag=0
severity: low
source: bse
stocks:
- '544619'
tags:
- index
- ipo
- bse-ipo-index
- listing
- equity
- sudeep-pharma
title: Addition to the BSE IPO INDEX
---

## Summary

SUDEEP PHARMA LIMITED (Exchange ticker: 544619) will be added to the BSE IPO Index effective at the open of December 02, 2025. The company is being listed on BSE effective November 28, 2025. This is a standard index inclusion following the company's initial public offering and listing.

## Key Points

- SUDEEP PHARMA LIMITED (ticker: 544619) listing on BSE effective November 28, 2025
- Stock will be added to BSE IPO Index effective December 02, 2025 at market open
- Addition included in end-of-day corporate action file (*.SDE)
- Action follows reference to Notice No: 20251127-58

## Regulatory Changes

No regulatory changes. This is a routine index composition update following an IPO listing.

## Compliance Requirements

No specific compliance requirements for market participants. Index tracking funds and portfolio managers tracking the BSE IPO Index may need to adjust their holdings to reflect the new composition.

## Important Dates

- **November 28, 2025**: SUDEEP PHARMA LIMITED listing effective on BSE
- **December 02, 2025**: Addition to BSE IPO Index effective at market open

## Impact Assessment

**Market Impact**: Low. This is a routine index addition following an IPO. The BSE IPO Index tracks recently listed companies, and additions are expected as new IPOs occur.

**Operational Impact**: Minimal. Index funds and ETFs tracking the BSE IPO Index will need to rebalance portfolios to include the new constituent. The corporate action file has been updated to facilitate automated processing by market systems.

**Investor Impact**: Informational for investors tracking the BSE IPO Index. No action required for general market participants.